MX2024009755A - Metodos de purificacion de un producto. - Google Patents

Metodos de purificacion de un producto.

Info

Publication number
MX2024009755A
MX2024009755A MX2024009755A MX2024009755A MX2024009755A MX 2024009755 A MX2024009755 A MX 2024009755A MX 2024009755 A MX2024009755 A MX 2024009755A MX 2024009755 A MX2024009755 A MX 2024009755A MX 2024009755 A MX2024009755 A MX 2024009755A
Authority
MX
Mexico
Prior art keywords
product
methods
purifying
affinity chromatography
purification
Prior art date
Application number
MX2024009755A
Other languages
English (en)
Spanish (es)
Inventor
Andreas Sebastian Zurbriggen
Carole In-Albon
Original Assignee
Kodiak Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kodiak Sciences Inc filed Critical Kodiak Sciences Inc
Publication of MX2024009755A publication Critical patent/MX2024009755A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • C07K16/248—IL-6
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/31—Immunoglobulins specific features characterized by aspects of specificity or valency multispecific
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/565—Complementarity determining region [CDR]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
MX2024009755A 2022-02-10 2023-02-09 Metodos de purificacion de un producto. MX2024009755A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202263267810P 2022-02-10 2022-02-10
PCT/US2023/062322 WO2023154822A2 (en) 2022-02-10 2023-02-09 Methods of purifying a product

Publications (1)

Publication Number Publication Date
MX2024009755A true MX2024009755A (es) 2024-08-20

Family

ID=87521638

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2024009755A MX2024009755A (es) 2022-02-10 2023-02-09 Metodos de purificacion de un producto.

Country Status (10)

Country Link
US (1) US20230250133A1 (enExample)
EP (1) EP4476237A2 (enExample)
JP (1) JP2025505696A (enExample)
KR (1) KR20240142564A (enExample)
CN (1) CN119032099A (enExample)
AU (1) AU2023217074A1 (enExample)
CA (1) CA3251000A1 (enExample)
IL (1) IL314472A (enExample)
MX (1) MX2024009755A (enExample)
WO (1) WO2023154822A2 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015035342A2 (en) 2013-09-08 2015-03-12 Oligasis Llc Factor viii zwitterionic polymer conjugates
AU2018250695A1 (en) 2017-04-14 2019-11-07 Kodiak Sciences Inc. Complement factor D antagonist antibodies and conjugates thereof
US12071476B2 (en) 2018-03-02 2024-08-27 Kodiak Sciences Inc. IL-6 antibodies and fusion constructs and conjugates thereof
AU2020364071A1 (en) 2019-10-10 2022-05-26 Kodiak Sciences Inc. Methods of treating an eye disorder
WO2025073922A1 (en) * 2023-10-04 2025-04-10 Sartorius Bia Separations D.O.O. Enhanced chromatographic separations of components in a mixture by employing chaotropic elution
WO2025184423A1 (en) * 2024-02-29 2025-09-04 Kodiak Sciences Inc. Cell-surface-targeting-domain-polymer-payload conjugate
US20260092109A1 (en) * 2024-09-06 2026-04-02 Eyebiotech Limited Multivalent fzd4, wnt co-receptor, and vegf receptor molecules and uses thereof
US20260092125A1 (en) * 2024-09-06 2026-04-02 Eyebiotech Limited Multivalent fzd4, wnt co-receptor, and vegf binding molecules and uses thereof
WO2026075981A1 (en) * 2024-10-01 2026-04-09 Regeneron Pharmaceuticals, Inc. Methods of analyzing heterodimeric proteins
CN119524125A (zh) * 2024-11-28 2025-02-28 北海康成(苏州)生物制药有限公司 一种欧莫扑拜单抗原液的生产方法及欧莫扑拜单抗原液
CN119454939A (zh) * 2024-11-28 2025-02-18 北海康成(苏州)生物制药有限公司 一种欧莫扑拜单抗原液及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7045314B2 (en) * 2000-04-04 2006-05-16 Baxter International Inc. Method for the production of bacterial toxins
RU2011137030A (ru) * 2009-03-11 2013-04-20 УАЙТ ЭлЭлСи Способы очистки малых модулярных иммунофармацевтических белков
AU2012328880B2 (en) * 2011-10-24 2017-02-23 Halozyme, Inc. Companion diagnostic for anti-hyaluronan agent therapy and methods of use thereof
ES2895752T3 (es) * 2014-01-03 2022-02-22 Hoffmann La Roche Anticuerpos biespecíficos anti-hapteno/anti-receptor de la barrera hematoencefálica, complejos de los mismos y su uso como lanzaderas a través de la barrera hematoencefálica
BR112016014969A2 (pt) * 2014-01-15 2018-01-23 Hoffmann La Roche polipeptídeo, formulação farmacêutica e uso de um polipeptídeo
EP3054007A1 (en) * 2015-02-09 2016-08-10 Institut National De La Sante Et De La Recherche Medicale (Inserm) Recombinant adeno-associated virus particle purification comprising an immuno-affinity purification step
JP6959912B2 (ja) * 2015-09-23 2021-11-05 ジェネンテック， インコーポレイテッド 抗ｖｅｇｆ抗体の最適化変異体
KR20250057128A (ko) * 2015-12-30 2025-04-28 코디악 사이언시스 인코포레이티드 항체 및 이의 접합체
US12071476B2 (en) * 2018-03-02 2024-08-27 Kodiak Sciences Inc. IL-6 antibodies and fusion constructs and conjugates thereof
US20210254073A1 (en) * 2020-02-04 2021-08-19 Cornell University Methods for capture and analysis of macromolecular complexes

Also Published As

Publication number Publication date
KR20240142564A (ko) 2024-09-30
CA3251000A1 (en) 2023-08-17
WO2023154822A3 (en) 2023-09-21
IL314472A (en) 2024-09-01
WO2023154822A2 (en) 2023-08-17
EP4476237A2 (en) 2024-12-18
WO2023154822A8 (en) 2024-04-04
AU2023217074A1 (en) 2024-08-15
US20230250133A1 (en) 2023-08-10
JP2025505696A (ja) 2025-02-28
CN119032099A (zh) 2024-11-26

Similar Documents

Publication Publication Date Title
WO2023154822A8 (en) Methods of purifying a product
De Luca et al. Downstream processing of therapeutic peptides by means of preparative liquid chromatography
MX2015005178A (es) Purificacion de polipeptidos usando ultrafiltracion de flujo tangencial de etapa doble.
Roe Protein purification applications: a practical approach
PL374311A1 (en) Methods for purifying protein
WO2002083710A3 (en) Removal of bacterial endotoxin in a protein solution by immobilized metal affinity chromatography
EP2729570B1 (en) Reagent usable for the isolation and/or purification of nucleic acids
MX348178B (es) Método para purificar adamts13 recombinante y otras proteínas y sus composiciones.
RU2011137030A (ru) Способы очистки малых модулярных иммунофармацевтических белков
CN109096379B (zh) 一种枯草芽孢杆菌amep412蛋白的新功能及其抗菌肽的鉴定
US20250340589A1 (en) Purifying antibodies
Luong et al. A continuous affinity ultrafiltration process for trypsin purification
Careri et al. Analysis of food proteins and peptides by chromatography and mass spectrometry
Rito-Palomares et al. Generic application of an aqueous two-phase process for protein recovery from animal blood
Dyr et al. Separation used for purification of recombinant proteins
WO2020127505A1 (en) A method for removing nucleosomal contaminants from bioprocessing solutions
Gräslund et al. Integrated strategy for selective expanded bed ion-exchange adsorption and site-specific protein processing using gene fusion technology
Balekjian et al. Histones isolated from human parotid fluid
Mönster et al. One-step-purification of penicillin G amidase from cell lysate using ion-exchange membrane adsorbers
Garmidolova et al. Food-derived bioactive peptides-methods for purification and analysis
CN105112394A (zh) 一种能降解黄曲霉毒素b1的裂解酶的分离纯化方法
Recio et al. Method for the production of antibacterial peptides from biological fluids at an ionic membrane. Application to the isolation of nisin and caprine lactoferricin
Karabel’skii et al. Purification of the chimeric protein alburon16 from a culture medium of the yeast Pichia pastoris
CN116082471B (zh) 一种Cth TerA内含肽变体及其在生物法制备四肽-7中的应用
Miller et al. Biochemical characterization of the antimicrobial histone released by deoxyribonuclease and lactic acid